
Fulgent Genetics Hits New 52-Week High of $27.36, Reflecting Strong Growth
2025-11-10 17:21:52Fulgent Genetics, Inc. has achieved a new 52-week high, reflecting a strong performance over the past year. With a market capitalization of USD 682 million, the company, despite being loss-making, demonstrates resilience in the competitive biotechnology sector, highlighted by its financial metrics and recent stock performance.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






